2010 annual financial data

Innate Pharma S.A. - American Depositary Shares 2010 Operating margin

Innate Pharma S.A. - American Depositary Shares 2010 operating margin with veri…

Direct answer

Operating margin was -316.9%.

Operating income was -13,690,000 EUR and net income was -13,658,000 EUR.
Operating cash flow was -13,449,000 EUR.

Get free Innate Pharma S.A. - American Depositary Shares email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
4,320,000 EUR
Operating income
-13,690,000 EUR
Net income
-13,658,000 EUR
Operating cash flow
-13,449,000 EUR